This report provides exclusive insights into the COVID-19 impact on the Aptamers Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Aptamers Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Aptamers Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on the aptamers market provides an in-depth analysis of segments and sub-segments in the global as well as regional aptamers market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional aptamers market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global aptamers market. According to the report, the global aptamers market is projected to grow at a CAGR of 17.5% over the forecast period of 2019-2025.
Aptamers are the single-stranded peptide or oligonucleotide molecules that bind to the specific target molecule. They are used in laboratory diagnosis, pharmaceutical studies, drug discovery, molecular recognition, and treatment of certain diseases. Aptamers are commonly used in the treatment of AIDS owing to faster development than the antibodies which lead to curing of diseases very faster.
An increasing number of companies investing in this market is one of the major factors driving the growth of the global aptamers market across the globe. Furthermore, technological advancements and patent expiration of the systematic evolution of ligands by exponential enrichment technology help in the growth of the market. Besides, low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies also fuel the market growth. Additionally, high thermal stability is likely to increase the adoption of the aptamer that in turn is likely to boost the global aptamer market. However, less awareness about technologies in middle and low-income countries and inadequate regulatory structure may hamper the growth of the aptamers market during the forecast period.
In terms of region, the global aptamers market is divided into North America, Europe, Asia-pacific and the Rest of the World. North America is leading the global aptamers market due to constant technological advancements in technologies. Furthermore, an increasing number of companies coupled with rising research and development activities drives the growth of the market in the North American region. The U.S. is the largest market in the region due to favorable government initiatives and the growing number of research laboratories. Europe is expected to hold the second-largest region for the aptamers market during the forecast period. This is credited to increasing acceptance of emerging aptamer technologies, growing incidence of chronic diseases, and rising demand for aptamer-based therapeutics in European countries. However, Asia Pacific is expected to grow at a beneficial rate during the forecast period. This is attributed to the growing frequency of chronic diseases coupled with the growing demand for cost-effective therapeutics augments the market growth in the region. China and Japan are considered to be the most promising countries for growth opportunities in the Asia Pacific region.
The report on global aptamers market covers segments such as type, application, technology, and end user. On the basis of type, the sub-markets include DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. On the basis of application, the sub-markets include diagnostics, therapeutics development, and research and development. On the basis of technology, the sub-markets include selex, and other technologies. On the basis of end user, the sub-markets include academic and government research institutes, biotechnology and pharmaceutical companies, and contract research organizations.
The report provides profiles of the companies in the market such as AM Biotechnologies, LLC, Aptagen, LLC, Aptamer Sciences, Inc., Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NeoVentures Biotechnology, Inc., SomaLogic, Inc., TriLink BioTechnologies, Inc., Vivonics, Inc., and Aptamer Solutions, Ltd.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of aptamers market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.